{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:38:07Z","timestamp":1793907487327,"version":"4.8.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the correlation between serum 25-hydroxyvitamin D (25[OH]D) levels and diabetic peripheral neuropathy (DPN) in type 2 diabetes mellitus (T2DM) and to evaluate its predictive value for DPN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants were divided into three groups based on 25(OH)D levels: deficient, insufficient, and normal. The relationship between 25(OH)D and DPN, as well as the correlation of 25(OH)D and DPN with various indicators, was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to the non-DPN group (NDPN), the DPN group had significantly lower levels of 25(OH)D3 (22.10 \u00b1 0.77 vs. 24.45 \u00b1 0.66 ng\/mL) and total 25(OH)D (23.12 \u00b1 0.74 vs. 25.68 \u00b1 0.67 ng\/mL). In addition, significant differences were observed in body mass index (BMI), resting heart rate (RHR), triglyceride (TG), free triiodothyronine (FT3), and blood urea nitrogen (BUN) between the two groups (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Multivariate analysis identified 25(OH)D3, total 25(OH)D, FT3, BMI, and RHR as risk factors for DPN. The receiver operating characteristic (ROC) curve analysis revealed that the optimal cutoff value for 25(OH)D3 in predicting DPN in T2DM was 18.85 ng\/mL [area under the curve (AUC) 0.76, 95% confidence interval (CI): 0.697\u20138.823], while the optimal cutoff for total 25(OH)D was 19.94 ng\/mL (AUC 0.765, 95% CI: 0.703\u20130.828).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum 25(OH)D levels can serve as a simple and effective screening tool to predict the occurrence of DPN in patients with T2DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1541388","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T04:10:41Z","timestamp":1749442241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Correlation between serum 25-hydroxyvitamin D levels and peripheral neuropathy in type 2 diabetes mellitus"],"prefix":"10.3389","volume":"16","author":[{"given":"Senzhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Cho","year":"2022","journal-title":"Diabetes Res Clin Pr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1043-2760(01)00547-1","article-title":"New clues about vitamin D functions in the nervous system","volume":"13","author":"Garcion","year":"2002","journal-title":"Trends Endocrin Met"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03510.x","article-title":"Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes","author":"Shehab","year":"2012","journal-title":"Diabetes Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03672.x","article-title":"Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis","volume":"29","author":"George","year":"2012","journal-title":"Diabetic Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9115-5","article-title":"and diabetes mellitus","volume":"35","author":"Danescu","year":"2009","journal-title":"Endocrine"},{"key":"B7","first-page":"893","article-title":"Guidelines for the prevention and treatment of type 2 diabetes in China (2013 edition)","volume":"30","year":"2014","journal-title":"Chin J Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000459641","article-title":"The burden of diabetes: emerging data","volume":"60","author":"Maffi","year":"2017","journal-title":"Dev Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.050","article-title":"Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor","volume":"52","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031005","article-title":"Adipocytokines and insulin resistance","volume":"89","author":"Pittas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1882-4","article-title":"An immune origin of type 2 diabetes","volume":"48","author":"Kolb","year":"2005","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.suppl_2.ii15","article-title":"The diabetic neuropathies: types, diagnosis and management","author":"Llewelyn","year":"2003","journal-title":"J Neurol Neurosur Ps"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00581","article-title":"Role for insulin in diabetic neuropathy","volume":"10","author":"Grote","year":"2016","journal-title":"Front Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6505","article-title":"How to prevent the microvascular complications of type 2 diabetes beyond glucose control","volume":"356","author":"Valencia","year":"2017","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0555","article-title":"A systematic review and meta-analysis of \u03b1-lipoic acid in the treatment of diabetic peripheral neuropathy","volume":"167","author":"Han","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12902-020-00549-w","article-title":"Association of vitamin D2 and D3 with type 2 diabetes complications","volume":"20","author":"Ahmed","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2973","article-title":"Bioavailable vitamin D in obese children: the role of insulin resistance","volume":"100","author":"Miraglia del Giudice","year":"2015","journal-title":"J Clin Endocr Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1055\/a-1018-9078","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"127","author":"Petersmann","year":"2019","journal-title":"Exp Clin Endocr Diab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00371.2003","article-title":"High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells","volume":"286","author":"Vidotti","year":"2004","journal-title":"Am J Physiol-Renal"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1994.267.3.E356","article-title":"Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas","volume":"267","author":"Johnson","year":"1994","journal-title":"Am J Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170042","article-title":"Vitamin D deficiency and diabetes","volume":"474","author":"Berridge","year":"2017","journal-title":"Biochem J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1995.1078","article-title":"The effect of 1,25-dihydroxyvitamin D3 on insulin binding, insulin receptor mRNA levels, and isotype RNA pattern in U-937 human promonocytic cells","volume":"217","author":"Leal","year":"1995","journal-title":"Exp Cell Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.383","article-title":"Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells","volume":"47","author":"Maestro","year":"2000","journal-title":"Endocr J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.03.060","article-title":"The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor","volume":"349","author":"Dunlop","year":"2005","journal-title":"J Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1322","article-title":"1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice","volume":"146","author":"Gysemans","year":"2005","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i8.1057","article-title":"Is there a relationship between vitamin D with insulin resistance and diabetes mellitus","volume":"6","author":"Al-Shoumer","year":"2015","journal-title":"World J Diabetes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2022.03.012","article-title":"Vitamin D in the prevention and treatment of diabetic neuropathy","volume":"44","author":"Putz","year":"2022","journal-title":"Clin Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24310","article-title":"Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients","volume":"77","author":"Singleton","year":"2015","journal-title":"Ann Neurol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1509465","article-title":"Decreased vitamin D increase the risk for subclinical hypothyroidism in individuals with T2DM: a cross-sectional study","volume":"12","author":"Fang","year":"2023","journal-title":"Front Nutr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1541388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T04:10:42Z","timestamp":1749442242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1541388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":32,"alternative-id":["10.3389\/fendo.2025.1541388"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1541388","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"article-number":"1541388"}}